Can physiological cardiac reserve be measured non-invasively and does it determine exercise capacity in humans?
Non-invasive estimation of physiological cardiac reserve using CO2 rebreathing correlates strongly with aerobic capacity and exercise duration, offering a potential tool to assess cardiac impairment in heart failure.
Objective To investigate whether physiological cardiac reserve can be measured in man without invasive procedures and whether it is a major determinant of exercise capacity. Design Development of method of measurement and an observational study. Setting A regional cardiothoracic centre. Subjects 70 subjects with a wide range of cardiac function, from heart failure patients to athletes. Methods Subjects underwent treadmill, symptom limited cardiopulmonary exercise tests to measure aerobic exercise capacity (represented by V˙ o 2 max) and cardiac reserve. Cardiac output was measured non-invasively using the C O 2 rebreathing technique. Results Cardiac power output (CPO max ) at peak exercise was found to be significantly related to aerobic capacity: CPO max (W) = 0.35 + 1.5V˙ o 2 max (l/min), r = 0.87, p < 0.001. It also correlated well with exercise duration ( r = 0.62, p < 0.001), suggesting that cardiac reserve is a major determinant of exercise capacity. In the study, cardiac reserve ranged from 0.27 to 5.65 W, indicating a 20-fold difference between the most impaired cardiac function and that of the fittest subject. Conclusions A non-invasive method of estimating physiological cardiac reserve was developed. The reserve was found to be a major determinant of exercise capacity in a population of normal subjects and patients with heart disease. This method may thus be used to provide a clearer definition of the extent of cardiac impairment in patients with heart failure.
Cooke et al. (Sun,) studied this question.